Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Iu Milovanova

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Terapevticheskii Arkhiv|September 25, 2012
[Long-acting erythropoetin efficacy in the treatment of nephrogenic anemia in patients with chronic kidney disease during predialysis stage]Iu S Milovanov, L Iu Milovanova
Terapevticheskii Arkhiv|July 29, 2008
[Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage]Iu S Milovanov, L V Kozlovskaia, L Iu Milovanova
Terapevticheskii Arkhiv|August 7, 2014
[Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease]L Iu Milovanova, I A Dobrosmyslov, Iu S Milovanov
Terapevticheskii Arkhiv|July 27, 2011
[The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys]Iu S Milovanov, L V Kozlovskaia, L Iu Milovanova
Terapevticheskii Arkhiv|August 10, 2007
[Erythropoetin and iron preparations in the treatment of anemia in patients with chronic kidney disease of stage III-IV in systemic diseases]L V Kozlovskaia, Iu S Milovanov, A Iu Nikolaev, et al.
Terapevticheskii Arkhiv|August 19, 2003
[Intradialysis hypotension: causes and sequelae]L Iu Milovanova, A Iu Nikolaev, V V Safonov, et al.
Terapevticheskii Arkhiv|July 26, 2002
[Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis]L Iu Milovanova, A Iu Nikolaev, N L Lifshits, et al.
Terapevticheskii Arkhiv|October 6, 2009
[The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases]Iu S Milovanov, L V Lysenko, L Iu Milovanova, et al.
Terapevticheskii Arkhiv|July 23, 2013
[New markers of cardio-renal links in chronic kidney disease]L Iu Milovanova, Iu S Milovanov, L V Kozlovskaia, et al.
Terapevticheskii Arkhiv|May 29, 2014
[Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease]L Iu Milovanova, Iu S Milovanov, L V Kozlovskaia, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Terapevticheskii Arkhiv|September 25, 2012
[Long-acting erythropoetin efficacy in the treatment of nephrogenic anemia in patients with chronic kidney disease during predialysis stage]Iu S Milovanov, L Iu Milovanova
Terapevticheskii Arkhiv|July 29, 2008
[Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage]Iu S Milovanov, L V Kozlovskaia, L Iu Milovanova
Terapevticheskii Arkhiv|August 7, 2014
[Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease]L Iu Milovanova, I A Dobrosmyslov, Iu S Milovanov
Terapevticheskii Arkhiv|July 27, 2011
[The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys]Iu S Milovanov, L V Kozlovskaia, L Iu Milovanova
Terapevticheskii Arkhiv|August 10, 2007
[Erythropoetin and iron preparations in the treatment of anemia in patients with chronic kidney disease of stage III-IV in systemic diseases]L V Kozlovskaia, Iu S Milovanov, A Iu Nikolaev, et al.
Terapevticheskii Arkhiv|August 19, 2003
[Intradialysis hypotension: causes and sequelae]L Iu Milovanova, A Iu Nikolaev, V V Safonov, et al.
Terapevticheskii Arkhiv|July 26, 2002
[Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis]L Iu Milovanova, A Iu Nikolaev, N L Lifshits, et al.
Terapevticheskii Arkhiv|October 6, 2009
[The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases]Iu S Milovanov, L V Lysenko, L Iu Milovanova, et al.
Terapevticheskii Arkhiv|July 23, 2013
[New markers of cardio-renal links in chronic kidney disease]L Iu Milovanova, Iu S Milovanov, L V Kozlovskaia, et al.
Terapevticheskii Arkhiv|May 29, 2014
[Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease]L Iu Milovanova, Iu S Milovanov, L V Kozlovskaia, et al.
Pageof 2